Allan Jordan strongly believes that while big data is important and can change pharma, it should not just be gathered without reason. There needs to be a purpose, and purpose is the main thing driving his latest project.
The project in question is focused on exploiting genome sequencing efforts to discover new targets for cancer treatment. A huge opportunity for positive change. Download the Case Study to find out more.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.
Your experience on this site will be improved by allowing cookies.